Published in Br J Psychiatry on June 01, 2002
Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med (2009) 7.89
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry (2011) 5.46
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol (2011) 2.15
Inequitable access for mentally ill patients to some medically necessary procedures. CMAJ (2007) 1.66
In-hospital cardiac arrest is associated with use of non-antiarrhythmic QTc-prolonging drugs. Br J Clin Pharmacol (2006) 1.19
New Generation Antipsychotic Drugs and QTc Interval Prolongation. Prim Care Companion J Clin Psychiatry (2003) 1.13
Sudden death in patients receiving drugs tending to prolong the QT interval. Br J Clin Pharmacol (2009) 1.08
Drug-induced arrhythmia: pharmacogenomic prescribing? Eur Heart J (2012) 1.00
Thioridazine: resurrection as an antimicrobial agent? Br J Clin Pharmacol (2007) 0.95
Case ascertainment and estimated incidence of drug-induced long-QT syndrome: study in Southwest France. Br J Clin Pharmacol (2008) 0.93
Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions. Front Psychiatry (2014) 0.91
Antipsychotics and sudden death: is thioridazine the only bad actor? Br J Psychiatry (2002) 0.87
QT prolongation and Torsades de Pointes following overdose of ziprasidone and amantadine. J Med Toxicol (2007) 0.86
Antipsychotics and the Risks of Sudden Cardiac Death and All-Cause Death: Cohort Studies in Medicaid and Dually-Eligible Medicaid-Medicare Beneficiaries of Five States. J Clin Exp Cardiolog (2013) 0.85
Factors associated with the prescribing of olanzapine, quetiapine, and risperidone in patients with bipolar and related affective disorders. Pharmacotherapy (2011) 0.84
Electrocardiogram and cardiovascular changes in thioridazine and chlorpromazine poisoning. Eur J Clin Pharmacol (2004) 0.82
Pharmacoepidemiology of QT-interval prolonging drug administration in critically ill patients. Pharmacoepidemiol Drug Saf (2008) 0.81
Response of i(kr) and HERG currents to the antipsychotics tiapride and sulpiride. Korean J Physiol Pharmacol (2010) 0.81
Antipsychotics, HERG and sudden death. Br J Psychiatry (2003) 0.78
Dose-dependent effect of antipsychotic drugs on autonomic nervous system activity in schizophrenia. BMC Psychiatry (2012) 0.78
Development of a FLIPR assay for the simultaneous identification of MrgD agonists and antagonists from a single screen. J Biomed Biotechnol (2010) 0.78
A Comparative Study between Olanzapine and Risperidone Regarding Drug-Induced Electrocardiographic Changes. Cardiovasc Psychiatry Neurol (2014) 0.76
Ventricular repolarization measures for arrhythmic risk stratification. World J Cardiol (2016) 0.76
Comparative genomics of the eukaryotes. Science (2000) 26.62
Functional genomic analysis of cell division in C. elegans using RNAi of genes on chromosome III. Nature (2000) 9.82
QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet (2000) 6.78
A global profile of germline gene expression in C. elegans. Mol Cell (2000) 5.97
Lithium neurotoxicity at normal therapeutic levels. Br J Psychiatry (1993) 3.76
Dyspepsia in England and Scotland. Gut (1990) 2.73
Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology (1988) 2.60
Streptococcus pyogenes type 12 M protein gene regulation by upstream sequences. J Bacteriol (1987) 2.54
Screening for glaucoma in the community by non-ophthalmologically trained staff using semi automated equipment. Eye (Lond) (1990) 2.48
Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype. Mol Psychiatry (2008) 2.38
D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics (1997) 2.28
Autobiographical memory in depression: state or trait marker? Br J Psychiatry (1993) 2.24
Short latency potentials recorded from the neck and scalp following median nerve stimulation in man. Electroencephalogr Clin Neurophysiol (1977) 2.18
Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol (2008) 2.11
Sequencing and analysis of genes involved in the biosynthesis of a vancomycin group antibiotic. Chem Biol (1998) 2.02
Small DNA deletions creating avirulence in Streptococcus pyogenes. Science (1984) 1.92
PhyloBLAST: facilitating phylogenetic analysis of BLAST results. Bioinformatics (2001) 1.89
Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis. Development (1996) 1.88
Clinical characteristics of mephedrone toxicity reported to the U.K. National Poisons Information Service. Emerg Med J (2010) 1.88
Do we need thyroid follow-up registers? A cost-effective study. Lancet (1982) 1.87
Socioeconomic variation in injury in children and older people: a population based study. Inj Prev (2003) 1.82
Effect of silicon on gastrointestinal absorption of aluminium. Lancet (1993) 1.80
Raised levels of plasma interleukin-1beta in major and postviral depression. Acta Psychiatr Scand (2001) 1.80
Potentials evoked in human and monkey cerebral cortex by stimulation of the median nerve. A review of scalp and intracranial recordings. Brain (1991) 1.75
Nonmethylated transposable elements and methylated genes in a chordate genome. Science (1999) 1.75
Steering, entanglement, nonlocality, and the Einstein-Podolsky-Rosen paradox. Phys Rev Lett (2007) 1.68
Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. Mol Psychiatry (2010) 1.63
Do parents of children with caries choose to opt out of positive consent dental surveys in Wales? Br Dent J (2011) 1.63
Effects of intravenous methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis. Neurology (1998) 1.62
Resorption of dentine by isolated osteoclasts in vitro. Br Dent J (1984) 1.60
Aggressive behaviour in patients with schizophrenia is associated with catechol-O-methyltransferase genotype. Br J Psychiatry (2001) 1.56
Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int (1990) 1.55
Relapse in chronic depressives on withdrawal of L-tryptophan. Lancet (1990) 1.53
A neuropathological study of vascular factors in late-life depression. J Neurol Neurosurg Psychiatry (2001) 1.53
Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. Acta Psychiatr Scand (2013) 1.52
The neurocognitive performance of drug-free and medicated euthymic bipolar patients do not differ. Acta Psychiatr Scand (2009) 1.51
Influenza A/H1N1v in pregnancy: an investigation of the characteristics and management of affected women and the relationship to pregnancy outcomes for mother and infant. Health Technol Assess (2010) 1.49
A system for the electrophysiological monitoring of the spinal cord during operations for scoliosis. J Bone Joint Surg Br (1983) 1.47
The accident and emergency department management of deliberate self-poisoning. Br J Psychiatry (1988) 1.46
Genetic utility of broadly defined bipolar schizoaffective disorder as a diagnostic concept. Br J Psychiatry (2009) 1.45
Effects of medium acidification by alteration of carbon dioxide or bicarbonate concentrations on the resorptive activity of rat osteoclasts. J Bone Miner Res (1994) 1.45
Urinary chromatographic profiles in schizophrenia. Biol Psychiatry (1990) 1.42
The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. Brain (1991) 1.41
Lateral gene transfer and metabolic adaptation in the human parasite Trichomonas vaginalis. Mol Biol Evol (2000) 1.37
Water intoxication in patients with psychiatric illness. Br Med J (Clin Res Ed) (1985) 1.35
A special relationship between spherical and filamentous microorganisms in mature human dental plaque. Arch Oral Biol (1972) 1.34
A comparison of proxy measures of abdominal obesity in Chinese, European and South Asian adults. Diabet Med (1999) 1.31
Gene number in an invertebrate chordate, Ciona intestinalis. Proc Natl Acad Sci U S A (1998) 1.27
Are mobile speed cameras effective? A controlled before and after study. Inj Prev (2003) 1.26
Bactericidal/permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis. Clin Exp Immunol (1995) 1.24
Serial magnetization transfer imaging in acute optic neuritis. Brain (2004) 1.24
Cerebral white matter lesions in bipolar affective disorder: relationship to outcome. Br J Psychiatry (2001) 1.23
Cognitive vulnerability in patients with bipolar disorder. Psychol Med (2000) 1.22
Magnetisation transfer ratios and transverse magnetisation decay curves in optic neuritis: correlation with clinical findings and electrophysiology. J Neurol Neurosurg Psychiatry (1995) 1.21
Possible virus in schizophrenia and some neurological disorders. Lancet (1979) 1.21
Late onset hypothyroidism after subtotal thyroidectomy for hyperthyroidism: implications for long term follow-up. Br J Surg (1983) 1.20
Severe pulmonary hemorrhage and systemic vasculitis in association with circulating anti-neutrophil cytoplasm antibodies of IgM class only. Clin Nephrol (1989) 1.19
Overlapping functions of lysosomal acid phosphatase (LAP) and tartrate-resistant acid phosphatase (Acp5) revealed by doubly deficient mice. Development (2001) 1.19
The mineralization density of iliac crest bone from children with osteogenesis imperfecta. Calcif Tissue Int (1999) 1.19
An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology (1994) 1.18
Polygenic dissection of the bipolar phenotype. Br J Psychiatry (2011) 1.17
Modification of the home environment for the reduction of injuries. Cochrane Database Syst Rev (2006) 1.17
Tooth surfaces treated in situ with periodontal instruments. Scanning electron microscopic studies. Br Dent J (1972) 1.17
Spinal and sub-cortical evoked potentials following stimulation of the posterior tibial nerve in man. Electroencephalogr Clin Neurophysiol (1978) 1.15
Electrophysiological and cognitive function in young euthymic patients with bipolar affective disorder. Bipolar Disord (2001) 1.12
The N-terminal domains target TNF receptor-associated factor-2 to the nucleus and display transcriptional regulatory activity. J Immunol (1998) 1.10
Mutational accessibility of essential genes on chromosome I(left) in Caenorhabditis elegans. Mol Gen Genet (2000) 1.09
Breast cancer in thyroid disease: fact or fallacy? Lancet (1981) 1.08
Corticosteroids do not prevent optic nerve atrophy following optic neuritis. J Neurol Neurosurg Psychiatry (2003) 1.08
The role of somatosensory evoked potentials and nerve conduction studies in the surgical management of brachial plexus injuries. J Bone Joint Surg Br (1980) 1.08
Ventriculoperitoneal shunt block: what are the best predictive clinical indicators? Arch Dis Child (2002) 1.08
Diagnosis of brachial plexus traction lesions by sensory nerve action potentials and somatosensory evoked potentials. Injury (1981) 1.07
Inhibition of bone resorption by selective inactivators of cysteine proteinases. J Cell Biochem (1994) 1.06
Long-term remyelination after optic neuritis: A 2-year visual evoked potential and psychophysical serial study. Brain (2001) 1.06
Characteristics of patients with schizophrenia or neurological disorder and virus-like agent in cerebrospinal fluid. Lancet (1979) 1.06
Alteration of serum and urinary lipolytic activity with weight loss in cachectic cancer patients. Br J Cancer (1990) 1.05
Mood and neuropsychological function in depression: the role of corticosteroids and serotonin. Psychol Med (1998) 1.04
A comparison of neurocognitive impairment in younger and older adults with major depression. Psychol Med (2008) 1.03
Peripheral and central somatosensory nerve conduction defects in Friedreich's ataxia. J Neurol Neurosurg Psychiatry (1980) 1.03
Peptone, a low-cost growth-promoting nutrient for intensive animal cell culture. Cytotechnology (1994) 1.03
An 'interference" approach to the study of somatosensory evoked potentials in man. Electroencephalogr Clin Neurophysiol (1981) 1.03
The speed of post mortem change to the human skeleton and its taphonomic significance. Forensic Sci Int (1996) 1.02
Scanning electron microscopy of bone: instrument, specimen, and issues. Microsc Res Tech (1996) 1.02
Oral anticoagulants: a cost-effectiveness approach. J R Coll Physicians Lond (1985) 1.01
Investigation of brachial plexus traction lesions by peripheral and spinal somatosensory evoked potentials. J Neurol Neurosurg Psychiatry (1979) 1.01
5HT2 receptor changes in major depression. Biol Psychiatry (1990) 1.00
Osteoclast-like cells form in long-term human bone marrow but not in peripheral blood cultures. J Clin Invest (1989) 1.00
The effects of inhibitors of cysteine-proteinases and collagenase on the resorptive activity of isolated osteoclasts. Bone (1987) 0.99
Matching-to-sample deficits in patients with senile dementias of the Alzheimer and Lewy body types. Arch Neurol (1992) 0.99
Serotonin receptor changes in dementia of the Alzheimer type. J Neurochem (1984) 0.98
Sequential treatments of premature lambs with an artificial surfactant and natural surfactant. J Clin Invest (1981) 0.98
Somatosensory evoked potential monitoring in cervical surgery: identification of pre- and intraoperative risk factors associated with neurological deterioration. J Neurosurg (1996) 0.97
Premature lambs rescued from respiratory failure with natural surfactant: clinical and biophysical correlates. Pediatr Res (1982) 0.97
The relationship between premorbid neuroticism, cognitive dysfunction and persistence of depression: a 1-year follow-up. J Affect Disord (1995) 0.96
Antiglucocorticoid treatments for mood disorders. Cochrane Database Syst Rev (2008) 0.96
The relationship between the number of nuclei of an osteoclast and its resorptive capability in vitro. Anat Embryol (Berl) (1992) 0.96